ArticlePDF Available

Abstract and Figures

This study investigated the effects of acute caffeine ingestion following short-term creatine supplementation on an incremental cycling to exhaustion task. Twelve active males performed the task under three conditions: baseline condition (BASE, no ergogenic aid), creatine plus caffeine condition (CRE+CAF), and creatine with placebo condition (CRE+PLA). Following the establishment of BASE condition, participants were administered CRE+CAF (0.3 g•kg-1•day-1 of creatine for 5 days followed by 6 mg•kg-1 of caffeine 1-h prior to testing) and CRE+PLA (0.3 g•kg-1•day-1 of creatine for 5 days followed by 6 mg•kg-1 of placebo1-h prior to testing) in a double-blind, randomized crossover protocol. No significant differences were observed in relative maximal oxygen consumption (VO2max) (BASE vs. CRE+CAF vs. CRE+PLA; 51.7 ± 5.5 vs. 52.8 ± 4.9 vs. 51.3 ± 5.6 ml•kg-1•min-1; p > 0.05) and absolute VO2max (BASE vs. CRE+CAF vs. CRE+PLA; 3.6 ± 0.4 vs. 3.7 ± 0.4 vs. 3.5 ± 0.5 l•min-1; p > 0.05). Blood samples indicated significantly higher blood lactate and glucose concentrations in the CRE+CAF among those in the BASE or CRE+PLA condition during the test (p < 0.05). The time to exhaustion on a cycling ergometer was significantly longer for the CRE+CAF (1087.2 ± 123.9-s) compared with the BASE (1009.2 ± 86.0-s) or CRE+PLA (1040.3 ± 96.1-s). This study indicated that a single dose of caffeine following short-term creatine supplementation did not hinder the creatine-caffeine interaction. In fact, it lengthened the time to exhaustion during an incremental maximum exercise test. However, this regime might lead to the accumulation of lactate in the blood.
Content may be subject to copyright.
ORIGINAL ARTICLE
Effect of creatine plus caffeine supplements on time to exhaustion
during an incremental maximum exercise
CHIA LUN LEE
1
, JUNG CHARNG LIN
2
, & CHING FENG CHENG
3
1
Department of Recreational Sports Management, Yu Da University, Chaochiao Township, Taiwan, ROC,
2
Graduate
Institute of Sport Coaching Science, Chinese Culture University, Taipei, Taiwan, ROC, and
3
Department of Athletic
Performance, National Taiwan Normal University, Taipei, Taiwan, ROC
Abstract
This study investigated the effects of acute caffeine ingestion following short-term creatine supplementation on an
incremental cycling to exhaustion task. Twelve active males performed the task under three conditions: baseline condition
(BASE, no ergogenic aid), creatine plus caffeine condition (CRE CAF), and creatine with placebo condition
(CREPLA). Following the establishment of BASE condition, participants were administered CRE CAF
(0.3 g×kg
1
×day
1
of creatine for 5 days followed by 6 mg×kg
1
of caffeine 1 h prior to testing) and CRE PLA
(0.3 g×kg
1
×day
1
of creatine for 5 days followed by 6 mg×kg
1
of placebo 1 h prior to testing) in a double-blind,
randomized crossover and counterbalancing protocol. No significant differences were observed in relative maximal oxygen
consumption (V
˙O
2max
) (51.795.5, 52.894.9 and 51.395.6 ml×kg
1
×min
1
for BASE, CRECAF and CRE PLA,
respectively; P0.05) and absolute V
˙O
2max
(3.690.4, 3.790.4 and 3.590.5 l×min
1
for BASE, CRE CAF and
CREPLA, respectively; P0.05). Blood samples indicated significantly higher blood lactate and glucose concentrations
in the CRE CAF among those in the BASE or CRE PLA condition during the test (PB0.05). The time to exhaustion
on a cycling ergometer was significantly longer for CRE CAF (1087.29123.9 s) compared with BASE (1009.2986.0 s)
or CREPLA (1040.3996.1 s). This study indicated that a single dose of caffeine following short-term creatine
supplementation did not hinder the creatinecaffeine interaction. In fact, it lengthened the time to exhaustion during an
incremental maximum exercise test. However, this regime might lead to the accumulation of lactate in the blood.
Keywords: Aerobic capacity, ergogenic aids, grade exercise test, perceived exertion
Introduction
One ergogenic effect of caffeine (CAF, trimethyl-
xanthine) on exercise performance is a significant
increase in time to exhaustion (Flinn, Gregory,
McNaughton, Tristram, & Davies, 1990; Graham
& Spriet, 1995; Jackman, Wendling, Friars, &
Graham, 1996) and an increase in time trial perfor-
mance (Anderson et al., 2000; Wiles, Coleman,
Tegerdine, & Swaine, 2006). However, a number
of studies have indicated that CAF does not sig-
nificantly improve graded exercise performance
(Dodd, Brooks, Powers, & Tulley, 1991; Powers,
Byrd, Tulley, & Callender, 1983).
One study reported that supplementation with
creatine monohydrate (CRE) can significantly in-
crease work in time trials during a kayak ergometer
test in elite athletes (McNaughton, Dalton, & Tarr,
1998). Another study observed an improvement in
work to exhaustion at various exercise intensities for
CRE trials resulting from an increase in aerobic
phosphorylation (Rico-Sanz & Mendez Marco,
2000). However, several other studies failed to con-
firm the contention that CRE loading improves long-
term, high-intensity exercise performance (Balsom,
Harridege, Soderlund, Sjodin, & Ekblom, 1993;
Engelhardt, Neumann, Berbalk, & Reuter, 1998;
Izquierdo, Ibanez, Gonzalez-Badillo., & Gorostiaga,
2002; Thompson et al., 1996).
Ingestion of CAF can stimulate the secretion of
epinephrine (Jackman et al., 1996), which facilitates
Correspondence: Ching Feng Cheng, National Taiwan Normal University, Department of Athletic Performance, No. 88, Sec. 4, Ting-
Zhou Rd., Wen-shan District Taipei 116 Taiwan. E-mail: andescheng@ntnu.edu.tw
European Journal of Sport Science, July 2012; 12(4): 338346
ISSN 1746-1391 print/ISSN 1536-7290 online #2012 European College of Sport Science
http://dx.doi.org/10.1080/17461391.2011.573578
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
the uptake of exogenous creatine by muscle tissue,
increases the Na
,K
-adenosine triphosphatase
pump activity, and raises the level of Na
sarcolem-
mic gradient (Clausen, 1996). Vandenberghe et al.
(1996) suggested that intramuscular creatine trans-
porters and concentrations of phosphocreatine might
be increased by the influence of hormones (i.e.
catecholamine) (Snow & Murphy, 2001) and
Na
,K
-adenosine triphosphatase (Clausen &
Flatman, 1977).
For this reason, Vandenberghe et al. (1996)
measured the performance of a maximal isometric
contraction task following treatment with CRE
(0.5 g×kg
1
×day
1
) in combination with CAF (5
mg×kg
-1
×day
-1
) supplementation for 5 days. Vana-
koski, Kosunen, Meririnne and Seppala (1998)
examined the effects of a 45-minute cycling task at
65% maximum oxygen consumption (V
˙O
2max
) fol-
lowing 3 days of supplementation with CRE (7
mg×kg
1
×day
1
) and CAF (0.3 g×kg
1
×day
1
).
Hespel, Opt Eijnde and Van Leemputte (2002)
tested the relaxation time during a task comprising
30 intermittent contractions of the quadriceps mus-
cles following ingestion of CRE for 4 days (0.5
g×kg
1
×day
1
) and CAF for 3 days (5
mg×kg
1
×day
1
). Although these studies did not
confirm any benefits to exercise performance from
CRE plus CAF, they showed that the ratio of
muscular phosphocreatine/adenosine triphosphate
(PCr/ATP), concentrations of PCr (Vandenberghe
et al., 1996), and pharmacokinetic parameters of
CRE were unaffected by concomitant administration
of oral CAF (Vanakoski et al., 1998).
Doherty, Smith, Davison and Hughes (2002)
showed that acute ingestion of CAF (5 mg×kg
1
)
after 6 days of CRE (0.3 g×kg
1
×day
1
) supplemen-
tation with abstinence from CAF had an ergogenic
effect on running time to exhaustion (10.7% greater
than placebo trial) during a test of maximal accu-
mulated oxygen deficit, with exercise intensity
equivalent to 125% V
˙O
2max
. Interestingly, they
demonstrated that short-term, super high-intensity
exercise performance was improved following CAF
plus CRE loading on separate days. As yet, there has
been no clear explanation as to the means by which
CAF plus CRE influences physiological mechanisms
or endurance in tests such as an incremental max-
imum exercise test (IMET).
The primary purpose of this study was to determine
the effects of acute ingestion of CAF following short-
term oral CRE supplementation with abstinence from
CAF, as it relates to time to exhaustion during an
incremental maximum cycling test. The secondary
purpose was to investigate the effects of CRE plus
CAF on physiological responses, such as respiratory
and biochemical parameters. We hypothesize that
supplementation with CRE for 5 days prior to acute
CAF ingestion on the sixth day could improve time to
exhaustion during an IMET and increase metabolic
energy. Additionally, short-term CRE loading prior to
acute placebo ingestion is suggested to have a
negligible effect on cycling to volitional exhaustion.
Methods
Participants
Twelve males (age 2091.8 years, height 174.794.6
cm, body mass 69.1095.30 kg) studying at the
Department of Physical Education in the National
Taiwan Normal University were recruited for this
experiment, which was approved by the universitys
Human Research Ethics Committee. Before the first
trial, all participants completed a health-screening
questionnaire, signed a written informed consent
form, and answered questions regarding medical
history and the use of ergogenic aids. Results
indicated that they had not taken any medicine
within the previous three months and the volume
of CAF ingested was less than 50 ppm ×day
1
. All
participants were required to abstain from ingesting
any medication, caffeine and alcohol during the
study. All participants maintained regular physical
activity, but were asked to abstain from intense
exercise for 24 hours and fast for at least 4 hours
prior to visits to the laboratory. This reduced
any interference from exercise or food on the
experiment.
Experimental design
A double blind, randomized crossover and counter-
balancing experimental design was used. Each
participant visited the laboratory four times. During
the first visit, all participants were familiarized with
the cycling devices and protocol. All volunteers
participated in a practice session. During the
second visit, the baseline condition (BASE) was
established: an incremental cycling performance
test without any ergogenic aids. The participants
ingested CRE supplements for 5 days prior to the
third and fourth visits. On the sixth day, one hour
before the incremental cycling performance test,
each participant was administered either caffeine
(CRECAF) or a placebo (CRE PLA). The
third and fourth visits were separated by one month
to clear their systems of CRE as suggested by
Hultman, Soderlund, Timmons, Cederblad and
Greenhaff (1996).
Exercise procedure
After the participants arrived at the laboratory, their
body weight was measured and each individual was
Effect of creatine and caffeine on time to exhaustion 339
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
administered capsules of either CAF or the placebo.
After one hour, the participants began the test with a
standardized warm-up procedure of a 5-minute sub-
maximal cycling at 50 W and a brief stretching exercise
for the lower legs and ankles. Each participant initially
pedaled at a work rate of 50 W on a cycling ergometer
(Avantronic Cyclus II, h/p Cosmos
, Germany). Every
2 minutes, the load was increased by 30 W. Cardio-
pulmonary responses were measured during the IMET
using a portable cardiopulmonary indirect breath-by-
breath calorimetry system (MetaMax 3B, Cortex Bio-
physik, Leipzig, Germany). Three of the following five
criteria (McConnell, 1988) had to be met to ensure that
each participant attained maximal effort: (1) heart rate
within 10 bpm of predicted maximum; (2) plateau of
oxygen uptake (V
˙O
2
) defined as no change (B150
ml×min
1
)inV
˙O
2
from the previous test stage; (3)
respiratory exchange ratio (RER) 1.1; (4) ventilation
volume 100 l ×min
1
; and (5) a Borg rating of
perceivedexertion(RPE)17 on the 620 scale.
V
˙O
2
, heart rate (HR), RER and RPE were analysed
throughout the duration of the test. A Polar heart rate
monitor (Polar S810i
TM
,PolarElectroInc.,Finland)
measured the HR during testing. The Borg RPE was
measured immediately after each sprint, with a rating of
6 indicating ‘‘no exertion’’ and 20 indicating ‘‘maximal’’
exhaustion.
Supplementation
During the second visit, the participants repeated
IMET, however they did so without CRE or CAF
supplements. Two days after the second visit, the
participants ingested 0.3 g ×kg
1
×day
1
of CRE
(Phosphagen HP
TM
, EAS, Golden, CO) per day
for 5 days. They were instructed to mix the CRE
powder in warm water (250 ml) for better dissolu-
tion (Harris, Soderlund, & Hultman, 1992) and to
ingest the solution with food in the morning, mid-
day, afternoon, and evening. This method of supple-
menting CRE is effective for increasing muscle
creatine content in young males (Harris et al.,
1992; Preen et al., 2001). During these five days,
the participants were required to abstain from
beverages/foods containing caffeine, as suggested
by Doherty et al. (2002). Upon arrival at the
laboratory, the participants were provided with
either 6 mg×kg
1
of CAF (Sigma-Aldrich, Sydney,
Australia) or an equivalent volume of a placebo
(maltodextrin; Starmax Nutrition, Hereford, UK) 1
hour prior to testing. Previous studies (Anselme,
Collomp, Mercier, Ahma
¨idi, & Prefaut, 1992; Spriet
et al., 1992) showed that the ingestion of this dosage
of CAF can elicit a positive ergogenic effect without
any serious side effects.
Blood sampling and analysis
During each trial, approximately 12 ml of blood was
taken from the antecubital vein via standard vene-
puncture techniques. Blood samples were drawn at
rest (prior to ingestion of supplements and exercise
testing, pre-test), 1 hour after ingesting the CAF or
placebo (post-ingestion), and after the incremental
maximum cycling test (post-test). Blood (8 ml)
containing ethylenediaminetetraacetic acid (EDTA)
was centrifuged at 3000 rpm for 15 minutes and
stored at 288C before immediate analysis of the
plasma for concentrations of epinephrine (Ep)
and norepinephrine (NEp) via high performance
liquid chromatography (HPLC) LCL 300
(Chromsystems
, Munchen, Germany), following
the method of Hue et al. (2000). The remaining
blood sample (4 ml) was centrifuged directly for
15 minutes and stored at 858C for analysis of
serum free fatty acid (FFA) with an automated clinical
chemistry analyser (model TBA-200 FR, Toshiba,
Tokyo, Japan). Capillary blood samples (10 ml) were
taken from the earlobe of each participant at pre-test,
immediately after each stage, and after the IMET (post-
test). A Biosen C-Line Sport Analyser (EKF Diagnos-
tics, Magdeburg, Germany) was used to analyse the
blood for lactate and glucose concentrations.
Statistical analysis
A one-way ANOVA with repeated measures (SPSS
for Windows 11.0, SPSS, Inc., Chicago, IL, USA)
was used to determine the effects of CRE plus CAF
supplementation on time to exhaustion, physiologi-
cal responses, and blood samples. When a significant
F-value was achieved, pairwise comparisons were
performed using a Bonferroni post hoc procedure.
Intraclass correlation coefficients were computed to
assess the consistency or testretest reliability of the
three trials. The obtained coefficients were signifi-
cantly moderate to high (from 0.48 to 0.98) in all
physiological variables tested. This statistical ap-
proach was selected because the purpose of the
study was to compare the effects of these supple-
ments on the three trials, not with the factor of time.
The change in FFA, Ep and NEp levels during post-
ingestion was calculated and compared for the trials
of CRECAF and CRE PLA using a two-tailed
paired sample t-test. Statistical significance was set at
P50.05 in all cases. Data were expressed as
mean9standard deviation.
Results
Physical characteristics
Body mass showed no significant difference among
the BASE, CRECAF, and CREPLA conditions
340 Chia Lun Lee et al.
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
(BASE 69.1095.30 kg; CRECAF 69.9295.35
kg; CREPLA 69.7895.69 kg; P0.05). Follow-
ing ingestion of CAF capsules and the completion of
the test, two participants experienced a transient,
mild sense of anxiety, and one participant experi-
enced a slight stomachache.
Performance and physiological responses
Exercise time to exhaustion is shown in Figure 1.
The CRECAF condition achieved increases of
78.0 s and 46.9 s during IMET (F8.84, PB0.05),
compared with the BASE and CREPLA condi-
tions. No significant differences were noted with
regard to time to exhaustion during IMET between
BASE and CREPLA. Additionally, absolute
V
˙O
2max
(F1.58) and relative V
˙O
2max
(F0.83)
were not significantly different between BASE,
CRECAF, and CREPLA. Maximal HR in
CRECAF was significantly higher than in BASE
or CREPLA (F13.82), but no significant dif-
ference was observed between BASE and CRE
PLA (Table I).
Because all participants completed a workload of
230 W and were exhausted after at least 60 s under a
workload of 230 W, the differences in V
˙O
2
, HR,
RER and RPE were analysed for each 30 W interval
between 50 and 230 W. No significant effects of
supplementation on V
˙O
2
, HR and RER were found
between 50 W and 230 W load among the three
conditions, but the RPE at 230 W was significantly
lower in CRECAF than in the BASE or CRE
PLA (F7.28) (Table II).
Blood parameters
Figures 2, 3 and 4 illustrate the blood parameters. At
pre-test, no significant differences in blood glucose
or blood lactate concentrations were observed for
BASE, CRECAF and CRE PLA. During ex-
ercise, blood glucose was significantly increased in
CRECAF compared to BASE and CRE PLA at
each stage (Figure 2A). The concentration of blood
lactate in CRECAF was significantly higher than
in the CREPLA condition between 50 and 170 W
(Figure 2B).
At the time of exhaustion, CRECAF resulted in
significantly higher concentration of blood glucose
compared to BASE or CRE PLA; however, no
difference was observed between CRE PLA and
BASE (4.890.7, 6.090.7 and 5.190.5 mmol×l
1
for BASE, CRECAF and CRE PLA, respec-
tively). Additionally, the blood lactate in the
CRECAF condition at post-test was significantly
higher than that in the BASE or CREPLA conditions,
andthebloodlactatewassignificantlyincreasedinthe
CREPLA condition at post-test (9.791.9, 11.992.3
and 10.891.8 mmol×l
1
for BASE, CRECAF and
CREPLA, respectively; PB0.05).
A significant increase of 0.51 mmol ×l
1
in serum
FFA was observed in CRE CAF relative to
CREPLA at post-ingestion but not at pre-test or
post-test (Figure 3). No significant difference was
observed in serum FFA during the pre-test and post-
test among the BASE, CRECAF or CRE PLA
conditions (P0.05). Figure 4 shows that no
significant difference was observed between
CRECAF and CRE PLA in either plasma Ep
or NEp at any time. In addition, no significant
difference was noted in the level of plasma Ep or
NEp between the BASE, CRECAF or CRE
PLA conditions at pre-test or post-test (P0.05).
Discussion
This study was the first to examine the acute effects
of a single dose of CAF following short-term CRE
supplementation on time to exhaustion during an
incremental maximum cycling test. The results of
900
950
1000
1050
1100
1150
1200
1250
1300
Exercisetimetoexhaustion (sec)
BASE CRE+CAF CRE+PLA
*
Figure 1. Differences in time to exhaustion during an incremental
maximum cycling test for BASE, CRE CAF and CRE PLA.
$Signicantly different to CRE PLA (PB0.05). *Signicantly
different to baseline (PB0.05). Error bars indicate standard
deviation.
Table I. Maximal oxygen consumption (V
˙O
2max
) and maximal heart rate (HR
max
) in the three trials during the incremental maximum
cycling test.
Variable BASE CRE CAF CRE PLA
V
˙O
2max
(ml×kg
1
×min
1
) 51.795.5 52.894.9 51.395.6
V
˙O
2max
(l×min
1
) 3.690.4 3.790.4 3.590.5
HR
max
(bpm) 18798 19297* 18596
*Significantly different from BASE and CRE PLA (p B0.05). Values are mean9standard deviation.
Effect of creatine and caffeine on time to exhaustion 341
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
Table II. Oxygen uptake (V
˙O
2
), heart rate (HR), respiratory exchange ratio (RER), rating of perceived exertion (RPE) in the three trials during different work rates.
Variable 50 W 80 W 110 W 140 W 170 W 200 W 230 W
V
˙O
2
(ml×kg
1
×min
1
)
BASE 17.39 92.35 19.48 92.11 22.93 92.57 27.47 92.81 33.14 93.11 38.54 93.77 44.02 94.42
CRE CAF 17.08 91.98 18.66 91.91 22.08 91.87 26.83 92.11 32.31 93.08 37.16 93.06 42.52 93.40
CRE PLA 17.70 91.71 19.39 91.63 22.75 91.58 27.58 91.88 32.62 92.43 37.75 92.56 43.19 93.04
V
˙O
2
(l×min
1
)
BASE 1.19 90.11 1.33 90.10 1.57 90.11 1.88 90.13 2.27 90.15 2.64 90.17 3.02 90.22
CRE CAF 1.17 90.06 1.28 90.07 1.53 90.08 1.86 90.09 2.24 90.10 2.57 90.14 2.95 90.13
CRE PLA 1.23 90.10 1.34 90.09 1.57 90.09 1.90 90.09 2.26 90.13 2.61 90.12 2.98 90.16
HR (bpm)
BASE 105 911 109 911 119 911 132 911 144 911 157 912 168 911
CRE CAF 104 913 109 914 118 914 130 914 144 915 157 914 170 912
CRE PLA 107 910 111 99 122 99 134 99 146 99 157 98 167 98
RER
BASE 0.73 90.69 0.78 90.06 0.82 90.07 0.86 90.08 0.90 90.08 0.96 90.07 1.02 90.08
CRE CAF 0.75 90.05 0.82 90.06 0.86 90.06 0.89 90.08 0.94 90.07 0.98 90.07 1.04 90.93
CRE PLA 0.74 90.07 0.80 90.04 0.83 90.04 0.87 90.04 0.91 90.04 0.95 90.05 1.01 90.07
RPE
BASE 7 9189110921192129314931692
CRE CAF 8 9199210921192139214921592*
CRE PLA 8 9199211921292149215921792
*Significantly different from BASE and CRE PLA (PB0.05). Values are mean9standard deviation.
342 Chia Lun Lee et al.
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
the study showed that five days of CRE loading (0.3
g×kg
1
×day
1
) before a single dose of CAF (6
mg×kg
1
) increased IMET performance, blood
lactate, blood glucose and FFA concentrations, but
did not influence maximum oxygen consumption,
heart rate, RER or catecholamines.
Vanakoski et al. (1998) observed no difference in
heart rate between individuals taking CRE CAF
and those taking CRE during a 45-minute exercise at
constant 65% V
˙O
2max
. However, they did not
examine endurance or oxygen consumption during
the test. This study showed that average time to
exhaustion during an IMET with CRE CAF was
greater than that achieved with CRE PLA (4.51%
increase) or BASE (7.73% increase). Therefore, this
study determined that short-term loading of CRE
before acute ingestion of CAF can extend time to
exhaustion during an incremental maximum cycling
test. Supplementation with CRE can help to increase
total muscular concentrations of creatine and PCr
resynthesis (Greenhaff, Bodin, Soderlund, & Hult-
man, 1994; Hultman et al., 1996). The operation of
intracellular Ca
2
improved (Pulido et al., 1998) to
augment the availability of PCr for active sarcoplas-
mic reticulum (SR)-bound creatine kinase, increas-
ing the local supply of ATP to the SR-Ca
2
pump
(OGorman et al., 1997) and levels of creatine
transporter (Snow & Murphy, 2001). This could
be the explanation for the benefits of CRE.
Supplementation with CREPLA did not en-
hance long-term aerobic exercise performance in
either our study or previous studies. The ergogenic
potential of supplementation with CRE in endurance
performance has typically yielded either non-signifi-
cant results in the endurance of well-trained athletes
(Engelhardt et al., 1998; Izquierdo et al., 2002;
Thompson et al., 1996) or a negative impact on
prolonged, high-intensity endurance performance
(Balsom et al., 1993). This could be caused by
either a failure of CRE to enhance glycogen content
in muscle or an increase in body weight, which
retarded performance. Nevertheless, the present
study did not observe a significant increase in body
weight nor measure the glycogen content in the
muscles following supplementation with CRE
PLA or CRECAF. We suggest that further
studies could investigate this indistinct area.
Graham, Battram, Dela, El-Sohemy and Thong
(2008) found that concentrations of cyclic adenosine
monophosphate (cAMP) in muscles increased dur-
ing 7080% V
˙O
2max
exercise following acute inges-
tion of CAF. Thus, CAF probably acts directly on
0
2
4
6
8
10
Blood lactate (mmol l1)
BASE CRE+CAF CRE+PLA
0
2
4
6
8
10
Blood glucose (mmol l1)
BASE CRE+CAF CRE+PLA
(A)
(B)
*****
Pre-test 50 Watts 80 Watts 110 Watts 140 Watts170 Watts 200 Watts 230 Watts
††††††
**
Figure 2. Blood glucose (A) and lactate concentrations (B) at pre-test and each stage during an incremental maximum cycling test for
BASE, CRE CAF and CRE PLA. $Signicantly different to CRE PLA (PB0.05). *Signicantly different to baseline (PB0.05).
Error bars indicate standard deviation.
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
Pre-test Post-in
g
estion Post-test
Serum free fatty acid (mmol l1)
CRE+CAF CRE+PLA
Figure 3. Ser um free fatty acid in CRE CAF and CRE PLA
at pre-test, post-ingestion and post-test. $Signicantly different to
CRE PLA (PB0.05). Error bars indicate standard deviation.
Effect of creatine and caffeine on time to exhaustion 343
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
ryanodine receptors to release potential Ca
2
from
skeletal muscle SR. Additionally, an increase in time
to exhaustion might be explained by the participants
feeling a reduction in discomfort (Plaskett &
Cafarelli, 2001) or muscular pain (Motl, OConnor,
& Dishman, 2003) following ingestion of CAF. Our
findings indicate that ingestion of CRE plus CAF
significantly reduces RPE at 230 W, while partici-
pants were close to exhaustion. These results concur
with Doherty et al. (2002). CAF may also improve
high-intensity endurance performance by increasing
the circulation of epinephrine or by sympathetic
stimulation (Graham & Spriet, 1995), thereby de-
creasing RPE during intense exercise (Doherty &
Smith, 2005).
No previous research has examined the effect of
CRE plus CAF on V
˙O
2
or heart rate during an
incremental maximum cycling test. Observation of
V
˙O
2
, HR and RER at each workload demonstrated
no significant difference between the BASE,
CRECAF and CRE PLA trials (Table II).
Physiological responses were similar to those ob-
tained in previous studies (Dodd et al., 1991;
Gaesser & Rich, 1985; Powers et al., 1983), demon-
strating that the ingestion of 5 or 7 mg×kg
-1
of CAF
did not alter oxygen consumption, HR or RER but
significantly increases the levels of FFA and lactate in
the blood. Although high concentrations of FFA
were induced by the ingestion of CAF (Dodd et al.,
1991; Gaesser & Rich, 1985; Powers et al., 1983;
Raguso, Coggan, Sidossis, Gastaldelli, & Wolfe,
1996), the data of RER during exercise and con-
centrations of FFA after exercise did not demon-
strate a caffeine-mediated glycogen sparing effect
secondary to an increased rate of lipolysis (Dodd et
al., 1991; Graham et al., 2008; Graham, Helge,
MacLean, Kiens, & Richter, 2000). Thus, our data
is in agreement with Graham et al. (2000, 2008),
showing no support for the effect of CAF on
increased fat oxidation or inhibition of carbohydrate
catabolism.
The significant increase in blood lactate and
concentration of glucose in CRE CAF compared
to BASE or CREPLA are likely due to a reduction
in blood lactate clearance (Graham et al., 2000) and
a decrease in the uptake of glucose by active muscles
(Raguso et al., 1996). Muscle biopsy analysis
showed that intramuscular cAMP increased at work-
load of 70% V
˙O
2max
following ingestion of CAF
(Graham et al., 2000). This may be in responses to
muscle glycogen and glycolytic flux (Chesley, How-
lett, Heigenhauser, Hultman, & Spriet, 1998).
Although glucose-6-phosphate tends to be higher
and concentrations of glycogen in the muscle tend to
be lower after exercising at 70% V
˙O
2max
during
treatment with CAF, the difference was not signifi-
cant between the CAF and placebo trials (Graham et
al., 2000). However, the concentration of glycogen
in the muscle was not measured in this study, and the
actual mechanism behind lactate and glucose follow-
ing supplementation with CRECAF requires
further study. So far, no good explanation has been
provided (Chesley et al., 1998; Graham et al., 2000)
to describe the action of CAF on lactate or glucose in
muscle. In addition, the present study showed no
significant differences between the trials with regard
to Ep and NEp. No significant difference was found
in catecholamine levels at any time between the
CRECAF and CRE PLA conditions. This
might be due to the fact that only a single dose of
CAF was used in this study. The CAF dose might
not have been strong enough to produce an ob-
servable difference between the CAF and the place-
bo. Interpreting the results of plasma Ep and NEp in
our study was difficult, due to the large variations
observed. Further study is needed to clarify the
relationship between caffeine-induced changes in
catecholamine, blood lactate, glucose and an incre-
mental cycling endurance performance.
A number of studies have suggested that ingesting
caffeine in conjunction with creatine negates the
potential ergogenic value on the exercise perfor-
mance. The study clearly refutes these contentions
and uncovers a number of additive benefits. In
conclusion, five days of supplementation with CRE
with caffeine abstinence followed by the ingestion of
a single dose of caffeine one hour prior to exercise
improved time to exhaustion during an incremental
0
100
200
300
400
500
600
700
800
900
1000
Plasma epinephrine (pg ml1)
CRE+CAF CRE+PLA
0
200
400
600
800
1000
1200
1400
Pre-test Post-in
g
estion Post-test
Plasma norepinephrine (pg ml1)
CRE+CAF CRE+PLA
(B)
(A)
Figure 4. Plasma epinephrine (A) and norepinephrine (B) con-
centrations in CRE CAF and CRE PLA at pre-test, post-
ingestion and post-test. The plasma epinephrine and norepi-
nephrine concentrations are not signicantly different between
CRE CAF and CRE PLA at every point (P0.05). Error
bars indicate standard deviation.
344 Chia Lun Lee et al.
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
maximum cycling test and induced higher levels of
blood lactate and glucose throughout the test. In
practice, athletes who engage in high-intensity en-
durance exercise could benefit from the additive
effects of caffeine ingested after a short-term creatine
loading. However, the ingestion of caffeine results in
higher concentrations of blood lactate; therefore,
coaches and athletes should use this supplemental
strategy with caution.
References
Anderson, M.E., Bruce, C.R., Fraser, S.F., Stepto, N.K., Klein,
R., Hopkins, W. G., & Hawley, J.A. (2000). Improved 2000-
meter rowing performance in competitive oarswomen after
caffeine ingestion. International Journal of Sport Nutrition and
Exercise Metabolism,10, 464475.
Anselme, F., Collomp, K., Mercier, B., Ahma
¨idi, S., & Prefaut, C.
(1992). Caffeine increases maximal anaerobic power and blood
lactate concentration. European Journal of Applied Physiology
and Occupational Physiology,65, 188191.
Balsom, P.D., Harridge, S.D., Soderlund, K., Sjodin, B., &
Ekblom, B. (1993). Creatine supplementation per se does
not enhance endurance exercise performance. Acta Physiologi-
cal Scandinavica,149, 521523.
Chesley, A., Howlett, R.A., Heigenhauser, G.J., Hultman, E., &
Spriet, L.L. (1998). Regulation of muscle glycogenolytic ux
during intense aerobic exercise after caffeine ingestion. The
American Journal of Physiology,275, 596603.
Clausen, T. (1996). The Na
,K
pump in skeletal muscle:
quantication, regulation and functional signicance. Acta
Physiological Scandinavica,156, 227235.
Clausen, T., & Flatman, J.A. (1977). The effect of catecholamines
on Na
-K
transport and membrane potential in rat soleus
muscle. The Journal of Physiology,270, 383414.
Dodd, S.L., Brooks, E., Powers, S.K., & Tulley, R. (1991). The
effects of caffeine on graded exercise performance in caffeine
naive versus habituated participants. European Journal of
Applied Physiology and Occupational Physiology,62, 424429.
Doherty, M., & Smith, P.M. (2005). Effects of caffeine ingestion
on rating of perceived exertion during and after exercise: a
meta-analysis. Scandinavian Journal of Medicine and Science in
Sports,15,6978.
Doherty, M., Smith, P.M., Davison, R.C., & Hughes, M.G.
(2002). Caffeine is ergogenic after supplementation of oral
creatine monohydrate. Medicine and Science in Sports and
Exercise,34, 17851792.
Engelhardt, M., Neumann, G., Berbalk, A., & Reuter, I. (1998).
Creatine supplementation in endurance sports. Medicine and
Science in Sports and Exercise,30, 11231129.
Flinn, S., Gregory, J., McNaughton, L.R., Tristram, S., & Davies,
P. (1990). Caffeine ingestion prior to incremental cycling to
exhaustion in recreational cyclists. International Jour nal of
Sports Medicine,11, 188193.
Gaesser, G.A., & Rich, R.G. (1985). Inuence of caffeine on
blood lactate response during incremental exercise.
International Journal of Sports Medicine,6, 207211.
Graham, T.E., Battram, D.S., Dela, F., El-Sohemy, A., & Thong,
F.S. (2008). Does caffeine alter muscle carbohydrate and fat
metabolism during exercise? Applied Physiology, Nutrition and
Metabolism,33, 13111318.
Graham, T.E., Helge, J.W., MacLean, D.A., Kiens, B., & Richter,
E.A. (2000). Caffeine ingestion does not alter carbohydrate or
fat metabolism in human skeletal muscle during exercise.
Journal of Physiology,529, 837847.
Graham, T.E., & Spriet, L.L. (1995). Metabolic, catecholamine,
and exercise performance responses to various doses of
caffeine. Journal of Applied Physiology,78, 867874.
Greenhaff, P.L., Bodin, K., Soderlund, K., & Hultman, E.
(1994). Effect of oral creatine supplementation on skeletal
muscle phosphocreatine resynthesis. The American Journal of
Physiology,266, 725730.
Harris, R.C., Soderlund, K., & Hultman, E. (1992). Elevation of
creatine in resting and exercised muscle of normal participants
by creatine supplementation. Clinical Science,83, 367374.
Hespel, P., Opt Eijnde, B., & Van Leemputte, M. (2002).
Opposite actions of caffeine and creatine on muscle relaxation
time in humans. Journal of Applied Physiology,92, 513518.
Hue, O., Le Gallais, D., Boussana, A., Galy, O., Chamari, K.,
Mercier, B., & Prefaut, C. (2000). Catecholamine, blood
lactate and ventilatory responses to multi-cycle run blocks.
Medicine and Science in Sports and Exercise,32, 15821586.
Hultman, E., Soderlund, K., Timmons, J.A., Cederblad, G., &
Greenhaff, P.L. (1996). Muscle creatine loading in men.
Journal of Applied Physiology,81, 232237.
Izquierdo, M., Ibanez, J., Gonzalez-Badillo, J.J., & Gorostiaga,
E.M. (2002). Effects of creatine supplementation on muscle
power, endurance, and sprint performance. Medicine and
Science in Sports and Exercise,34, 332343.
Jackman, M., Wendling, P., Friars, D., & Graham, T.E. (1996).
Metabolic, catecholamine, and endurance responses to caffeine
during intense exercise. Journal of Applied Physiology,81, 1658
1663.
McConnell, T.R. (1988). Practical considerations in the testing of
V
˙O
2
max in runners. Sports Medicine,5,5768.
McNaughton, L.R., Dalton, B., & Tarr, J. (1998). The effects of
creatine supplementation on high-intensity exercise perfor-
mance in elite performers. European Journal of Applied Physiol-
ogy and Occupational Physiology,78, 236240.
Motl, R.W., OConnor, P.J., & Dishman, R.K. (2003). Effect of
caffeine on perceptions of leg muscle pain during moderate
intensity cycling exercise. The Journal of Pain: Official Journal of
the American Pain Society,4, 316321.
OGorman, E., Beutner, G., Dolder, M., Koretsky, A.P., Brdicz-
ka, D., & Wallimann, T. (1997). The role of creatine kinase in
inhibition of mitochondrial permeability transition. FEBS
Letters,414, 253257.
Plaskett, C.J., & Cafarelli, E. (2001). Caffeine increases endurance
and attenuates force sensation during submaximal isometric
contractions. Journal of Applied Physiology,91, 15351544.
Powers, S.K., Byrd, R.J., Tulley, R., & Callender, T. (1983).
Effects of caffeine ingestion on metabolism and performance
during graded exercise. European Journal of Applied Physiology
and Occupational Physiology,50, 301307.
Preen, D., Dawson, B., Goodman, C., Lawrence, S., Beilby, J., &
Ching, S. (2001). Effect of creatine loading on long-term sprint
exercise performance and metabolism. Medicine and Science in
Sports and Exercise,33, 814821.
Pulido, S.M., Passaquin, A.C., Leijendekka, W.J., Challet, C.,
Wallimann, T., & Ru
¨egg, U.T. (1998). Creatine supplementa-
tion improves intracellular Ca
2
handling and survival in mdx
skeletal muscle cells. FEBS Letters,439, 357362.
Raguso, C.A., Coggan, A.R., Sidossis, L.S., Gastaldelli, A., &
Wolfe, R.R. (1996). Effect of theophylline on substrate
metabolism during exercise. Metabolism,45, 11531160.
Rico-Sanz, J., & Mendez Marco, M.T. (2000). Creatine enhances
oxygen uptake and performance during alternating intensity
exercise. Medicine and Science in Sports and Exercise,32,
379385.
Snow, R.J., & Murphy, R.M. (2001). Creatine and the creatine
transporter: a review. Molcular and Cellular Biochemistry,224,
169181.
Effect of creatine and caffeine on time to exhaustion 345
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
Spriet, L.L., MacLean, D.A., Dyck, D.J., Hultman, E., Ceder-
blad, G., & Graham, T.E. (1992). Caffeine ingestion and
muscle metabolism during prolonged exercise in humans. The
American Journal of Physiology,262, 891898.
Thompson, C.H., Kemp, G.J., Sanderson, A.L., Dixon, R.M.,
Styles, P., Taylor, D.J., & Radda, G.K. (1996). Effect of
creatine on aerobic and anaerobic metabolism in skeletal
muscle in swimmers. British Journal of Sports Medicine,30,
222225.
Vanakoski, J., Kosunen, V., Meririnne, E., & Seppala, T. (1998).
Creatine and caffeine in anaerobic and aerobic exercise: effects
on physical performance and pharmacokinetic considerations.
International Jour nal of Clinical Pharmacology and Therapeutics,
36, 258262.
Vandenberghe, K., Gillis, N., Van Leemputte, M., Van Hecke, P.,
Vanstapel, F., & Hespel, P. (1996). Caffeine counteracts the
ergogenic action of muscle creatine loading. Journal of Applied
Physiology,80, 452457.
Wiles, J.D., Coleman, D., Tegerdine, M., & Swaine, I.L. (2006).
The effects of caffeine ingestion on performance time, speed
and power during a laboratory-based 1 km cycling time-trial.
Journal of Sports Sciences,24, 1165 1171.
346 Chia Lun Lee et al.
Downloaded by [National Taiwan Normal University] at 17:13 05 September 2012
... The studies finally included were 10 randomized PLA-controlled trials, seven double blind (Doherty et al., 2002;Hespel et al., 2002;Lee et al., 2011Lee et al., , 2012Pakulak et al., 2021;Vanakoski et al., 1998;Vandenberghe et al., 1996), two single blind (Jerônimo et al., 2017;Quesada & Gillum, 2013), and a partially blind trial (Trexler et al., 2016). Eight of the 10 studies included had a crossover design (Doherty et al., 2002;Hespel et al., 2002;Jerônimo et al., 2017;Lee et al., 2011Lee et al., , 2012Quesada & Gillum, 2013;Vanakoski et al., 1998;Vandenberghe et al., 1996), whereas the remaining studies had a parallel design (Pakulak et al., 2021;Trexler et al., 2016). ...
... The studies finally included were 10 randomized PLA-controlled trials, seven double blind (Doherty et al., 2002;Hespel et al., 2002;Lee et al., 2011Lee et al., , 2012Pakulak et al., 2021;Vanakoski et al., 1998;Vandenberghe et al., 1996), two single blind (Jerônimo et al., 2017;Quesada & Gillum, 2013), and a partially blind trial (Trexler et al., 2016). Eight of the 10 studies included had a crossover design (Doherty et al., 2002;Hespel et al., 2002;Jerônimo et al., 2017;Lee et al., 2011Lee et al., , 2012Quesada & Gillum, 2013;Vanakoski et al., 1998;Vandenberghe et al., 1996), whereas the remaining studies had a parallel design (Pakulak et al., 2021;Trexler et al., 2016). In total, there were 170 participants in the 10 studies (157 men and 13 women). ...
... In total, there were 170 participants in the 10 studies (157 men and 13 women). Eight of the 10 studies included had fewer than 20 participants (Doherty et al., 2002;Hespel et al., 2002;Jerônimo et al., 2017;Lee et al., 2011Lee et al., , 2012Quesada & Gillum, 2013;Vanakoski et al., 1998;Vandenberghe et al., 1996); only two assessed the effects of CAF and CRE in a larger group of subjects (Pakulak et al., 2021;Trexler et al., 2016). Most of the studies included participants aged between 18 and 25 years. ...
Article
There is some controversy regarding the interactions between creatine (CRE) and caffeine (CAF) supplements. The aim of this systematic review was to study whether such ergogenic interaction occurs and to analyze the protocol to optimize their synchronous use. The PubMed, Web of Science, MEDLINE, CINAHL, and SPORTDiscus databases were searched until November 2021 following the PRISMA guidelines. Ten studies were included. Three studies observed that CRE loading before an acute dose of CAF before exercise did not interfere in the beneficial effect of CAF, whereas one study reported that only an acute supplementation (SUP) of CAF was beneficial but not the acute SUP of both. When chronic SUP with CRE + CAF was used, two studies reported that CAF interfered in the beneficial effect of CRE, whereas three studies did not report interaction between concurrent SUP, and one study reported synergy. Possible mechanisms of interaction are opposite effects on relaxation time and gastrointestinal distress derived from concurrent SUP. CRE loading does not seem to interfere in the acute effect of CAF. However, chronic SUP of CAF during CRE loading could interfere in the beneficial effect of CRE.
... Several studies have been demonstrated that caffeine (4.5 -9 mg/kg) had no effect on muscle damage biomarkers following resistance exercise (Machado et al., 2008;Nosaka, Newton, & Sacco, 2002;Soleimani, Shakerian, & Ranjbar, 2017;Zarghami-Khameneh & Jafari, 2014). In contrast, there are studies reported that caffeine (5, 6, and 9 mg/kg) intake could enhance endurance exercise (Glaister, Muniz-Pumares, Patterson, Foley, & Mcinnes, 2015;Lee, Lin, & Cheng, 2011;Wu & Lin, 2010), particularly prolonged and exhaustive exercise (Wu & Lin, 2010). To our knowledge, however, there is no research investigated the effects of caffeine on biomarkers of muscle damage following both resistance exercise and exhaustive performance in long-distance runners. ...
... Surprisingly, our results showed that caffeine increased time to exhaustion during exhaustive incremental treadmill test following resistance exercises compared to PLA. The explanation of this result might be attributed to beneficial binds of caffeine to ryanodine receptor (Lee et al., 2011), which elicit calcium kinetics from sarcoplasmic reticulum (Owens et al., 2019;Trexler et al., 2016), potentiating sustained contraction cycle, and subsequently improved performance. Additionally, the inhibition of adenosine uptake due to caffeine consumption (Azevedo, Silva-Cavacante, Gualano, Lima-Silva, & Bertuzzi, 2016;Machado et al., 2008;Nawrot et al., 2003) activate release of excitatory neurotransmitter (Glaister et al., 2015;Owens et al., 2019), namely dopamine (Reolands & Meeusen, 2012). ...
... This excitation is thought to alter pain sensation (Duncan et al., 2013;Glaister et al., 2015;Graham, 2001;Tarnopolsky, 2010), decrease rating of perceived exertion (Astorino et al., 2008;Duncan et al., 2013), and thus delay the onset of fatigue (Tarnopolsky, 2010). Lee et al. (2011) found that caffeine (6 mg/kg) + creatine (.3 g/kg/day for 5 days) increased time to exhaustion on a cycling ergometer (1087.2 ± 123.9 s) compared to creatine + placebo (1040.3 ...
Article
Full-text available
The present study was designed to investigate the acute effect of caffeine on muscle damage biomarkers (creatine kinase, lactate dehydrogenase, creatine kinase MB, and myoglobin) measured before, immediately after, and 24 h after a single session of resistance exercises followed by exhaustive incremental test. In addition, the effect of caffeine intake on time to exhaustion during exhaustive incremental test was determined. Fifteen male long-distance runners (30.67 ± 3.40 yrs.) performed two consecutive trials (7 days apart). Athletes were assigned randomly either to ingest caffeine (6 mg/kg) 1 h prior to exercise or placebo using a double-blind crossover design. Each trial consisted of 5 resistance exercises followed by exhaustive incremental test. Blood samples were collected before, immediately, and 24 h after each trial. The independent t test of data showed no significant differences in biomarkers of muscle damage at all time points between trials (p > .05). Using paired sample t test, data revealed that caffeine increased the time to exhaustion (45.78 ± 2.42 min) during exhaustive incremental test compared to the placebo (43.83 ± 2.21 min) (p = .001). In conclusion, 6 mg/kg of caffeine 1 hour prior to resistance exercises followed by exhaustive incremental test had no effect on muscle damage biomarkers in long-distance runners probably due to mechanical stress precisely affected fast twitch fibres rather than slow twitch fibres. However, the increased time to exhaustion due to caffeine consume may attributed to dampened pain sensation.
... This increases vigilance (Urquiza & Veiyra, 2013), which is required for athletic population. It has been demonstrated that caffeine is used as an ergogenic aids by athletes (Lee, Lin, & Cheng, 2011) to improve exercise capacity (Magko & Kavouras, 2005) and delay onset of fatigue (Wallman, Goh, & Guelfi, 2010). In addition, caffeine has an ergogenic effect, particularly in aerobic exercise due to free fatty acids (FFAs) mobilization and cells utilization (Tarnopolsky, 2010). ...
... reported increased time to exhaustion(Cox et al., 2002;Lee et al., 2011; Glaister, Muniz-Pumares, Patterson, Foley, & Mcinnes, 2016), decreased total sprint time (Abumoh'd, Matalqah, & Qasim, 2016), improved cycling work(Desbrow et al., 2011;Wallman et al., 2010), increased power output(Coso et al., 2012), and decreased rating of perceived exertion (RPE)(Glaister et al., 2016). ...
Article
Full-text available
Pituitary apoplexy is a rare, life-threatening clinical syndrome caused by infarction and/or haemorrhage of the tumour. Resistance to cabergoline is rare, but it has been described in a small percentage of patients with macroprolactinoma. We report a case of apoplexy within a macroprolactinoma, with subsequent shrinkage of the adenoma but without prolactin normalisation. The patient, a 33-year-old male soccer player with a 5-year history of a macroprolactinoma, was admitted to the hospital with a severe frontal headache, hypotension and muscle stiffness lasting 7 days. Magnetic resonance imaging (MRI) showed obvious pituitary macroprolactinoma (1.8 × 1.8 × 2.0 cm) with azoospermia. He started treatment with cabergoline (0.5 mg thrice a week). 3.5 years later, MRI of the pituitary demonstrated an increase in the adenoma size with haemorrhage, and approximately 8 months later zoospermia was achieved. The patient then affected by pituitary apoplexy coinciding with adenoma shrinkage. Although he continued intake of medication and some symptoms were disappeared, his PRL level did not return to the normal range. He decided to continue cabergoline therapy without surgery. Follow-up was discontinued by the patient.
... This increases vigilance (Urquiza & Veiyra, 2013), which is required for athletic population. It has been demonstrated that caffeine is used as an ergogenic aids by athletes (Lee, Lin, & Cheng, 2011) to improve exercise capacity (Magko & Kavouras, 2005) and delay onset of fatigue (Wallman, Goh, & Guelfi, 2010). In addition, caffeine has an ergogenic effect, particularly in aerobic exercise due to free fatty acids (FFAs) mobilization and cells utilization (Tarnopolsky, 2010). ...
... Several studies on the effect of caffeine have been focused on physical performance and reported increased time to exhaustion (Cox et al., 2002;Lee et al., 2011;Glaister, Muniz-Pumares, Patterson, Foley, & Mcinnes, 2016), decreased total sprint time (Abumoh'd, Matalqah, & Qasim, 2016), improved cycling work (Desbrow et al., 2011;Wallman et al., 2010), increased power output (Coso et al., 2012), and decreased rating of perceived exertion (RPE) (Glaister et al., 2016). ...
Article
Full-text available
The present study was designed to investigate the acute effect of caffeine on prolactin, dopamine, thyroxine, and testosterone responses to 12 min running test. In addition, the effect of caffeine intake on achieved distance during the test was determined. Eleven male sub-elite long-distance runners (mean ± SD: age 23.17 ± 3.25 yrs; height 171.90 ± 3.43 m; body mass 65.73 ± 6.03 kg; BMI 22.20 ± 1.31; training volume 9.27 ± 3.13 h/week, VO2max 49.60 ± 5.60 ml/kg/min) performed two consecutive trials (7 days apart). Athletes were assigned randomly either to ingest 6 mg/kg of caffeine 1 h prior to exercise or placebo using a double-blind, placebo-controlled crossover design. During the test, participants were asked to run the farthest distance they could possibly achieve. Blood and urine samples were collected immediately at the end of each trial. Using paired sample t test, data showed significantly lower serum prolactin levels in the caffeine trial (20.427 ± 3.503 ng/ml) than in the placebo (22.690 ± 3.318 ng/ml) (P < 0.001), whereas dopamine was significantly elevated with caffeine than with placebo (250.181 ± 69.697 μg/g; 217.363 ± 59.287 μg/g for caffeine and placebo, respectively; P = 0.020). No differences existed between trials for testosterone (P = 0.614). The achieved distance during 12 min running was significantly more (3828.56 ± 153.47 min) with caffeine ingestion compared with the placebo (3787.81 ± 144.92 min) (P = 0.002). In conclusion, 6 mg/kg of caffeine 1 hour prior to short intense aerobic exercise (12 min running test) had positively effect on achieved distance and hormonal responses in long-distance runners probably due to increased dopaminergic pathway activity.
... Son illərdə alimlərin apardığı tədqiqatlarda kofeindən (12), kreatindən (11), salbutamoldan (18) istifadə olunmuşdur. Müəyyən olunmuşdur ki, hüdud yüklərinin icrası zamanı kofeinin kəskin qəbulu, kreatinin uzunmüddətli qəbuluna nəzarən işin icra olunmasını xeyli yüksəldir (14). Nottexem Universitetinin Kral tibb dofaminin, noradrenalinin farmakoloji preparat kimi daxil edilməsi uzunmüddətli işlər zamanı yorulmanın inkişafını sürətləndirməsi də elmi -tədqiqat işlərinin köməyi ilə sübut olunmuşdur. ...
Article
Beləliklə, aparılmış çoxsaylı elmi – tədqiqat işlərinin köməyi ilə idmançı orqanizminin fiziki iş qabiliyyətinin və adaptiv imkanlarının yüksəldilməsi üçün farmokoloji preparatların tətbiqinin metodlarının işlənib hazırlanması və əsaslandırılması həyata keçirilmişdir. Beləki, idman iş qabiliyyəti ilə bioloji ritmlər arasında qarşılıqlı əlaqə və rol müəyyən olunmuşdur. Hiperoksiyanın, hipoksiyanın və digər ətraf mühitin amillərinin idmançıların funksional vəziyyətinə təsiri tədqiq olunmuşdur. Aparılmış eksperimental tədqiqatların köməyi ilə hiperoksik qaz qarışıqlarının və transkranial elektrostimulyasiyanın, həmçinin bioloji ritmlərin qeyd olunması və onlardan idmançıların orqanizminin funksional vəziyyətinin yaxşılaşdırılması və fiziki iş qabiliyyətinin yüksəldilməsində effektiv istifadəsi əksini tapmışdır. Beləliklə, limfodrenaj aparatı qan dövranının gücləndirməklə əzələlərdə trofik prosesləri yaxşılaşdırır.
... Increased CHO metabolism was based on RER data; however, FFA and glycerol suggested a nonsignificant increase in fat metabolism. These seemingly contradictory findings of decreased fat metabolism reported by gas analysis data while blood biomarkers suggest increased lipolysis were reported by others (Casal & Leon, 1985;Lee et al., 2012;Spriet et al., 1992;Wells et al., 1985) with authors' interpretation varying. While not mechanistic, our findings suggest the method used can yield differential results regarding fat metabolism after ingesting CAF and should be considered when interpreting CAF's effect. ...
Article
Full-text available
Whether caffeine (CAF) increases fat metabolism remains debatable. Using systematic review coupled with meta-analysis, our aim was to determine effects of CAF on fat metabolism and the relevant factors moderating this effect. Electronic databases PubMed, SPORTDiscus, and Web of Science were searched using the following string: CAF AND (fat OR lipid) AND (metabolism OR oxidation). A meta-analytic approach aggregated data from 94 studies examining CAF’s effect on fat metabolism assessed by different biomarkers. The overall effect size (ES) was 0.39 (95% confidence interval [CI] [0.30, 0.47], p < .001), indicating a small effect of CAF to increase fat metabolism; however, ES was significantly higher ( p < .001) based on blood biomarkers (e.g., free fatty acids, glycerol) (ES = 0.55, 95% CI [0.43, 0.67]) versus expired gas analysis (respiratory exchange ratio, calculated fat oxidation) (ES = 0.26, 95% CI [0.16, 0.37]), although both were greater than zero. Fat metabolism increased to a greater extent ( p = .02) during rest (ES = 0.51, 95% CI [0.41, 0.62]) versus exercise (ES = 0.35, 95% CI [0.26, 0.44]) across all studies, although ES was not different for studies reporting both conditions (ES = 0.49 and 0.44, respectively). There were no subgroup differences based on participants’ fitness level, sex, or CAF dosage. CAF ingestion increases fat metabolism but is more consistent with blood biomarkers versus whole-body gas exchange measures. CAF has a small effect during rest across all studies, although similar to exercise when compared within the same study. CAF dosage did not moderate this effect.
... L. Lee, Lin, and Cheng 2011), as well as prolongs time to exhaustion during a maximum incremental cycling test (C. L. Lee, Lin, and Cheng 2012) and time to exhaustion at 125% of VO 2 max (Doherty et al. 2002), when compared to CRE alone or PLA. Previous studies found that peak and mean power during sprints are greater after CRE (Barber et al. 2013;Yáñez-Silva et al. 2017), and conflicting after CAF (Grgic 2018;Grgic et al. 2020; Lopes-Silva et al. 2019) alone. ...
Article
Creatine (CRE) and caffeine (CAF) have been used as ergogenic aids to improve exercise performance. The present study reviewed the current evidence supporting the additional use of CAF intake during or after the CRE loading on exercise performance. The search was carried out in eight databases, with the methodological quality of the studies assessed via the QualSyst tool. From ten studies that met the criteria for inclusion, six had strong, three moderate, and one weak methodological quality. CAF was ingested ∼1 h before the performance trial (5–7 mg.kg⁻¹) after a CRE loading period (5–6 days with 0.3 g.kg⁻¹.d⁻¹) in five studies, with the combination CAF + CRE providing additional ergogenic effect compared to CRE alone in three of these studies. Furthermore, CAF was ingested daily during the CRE loading protocol in five studies, with CAF showing additive benefits compared to CRE alone only in one study (3 g.d⁻¹ of CRE during 3 days + 6 mg.kg⁻¹ of CAF for 3 days). The combination CAF + CRE seems to provide additional benefits to exercise performance when CAF is acutely ingested after a CRE loading. There is, however, no apparent benefit in ingesting CAF during a CRE loading period.
Article
Introdução: A pressão a que os jovens atletas de alta competição estão sujeitos leva procura de alternativas para alcançarem vantagem competitiva, sendo os suplementos nutricionais e as substâncias ergogénicas uma alternativa frequentemente equacionada. Métodos: Pesquisa na Web Of Science de artigos dos últimos 20 anos, utilizando a query ((sport OR exercise) AND supplement AND adolescent). Resultados/Discussão: A suplementação com ferro está associada a melhoria significativa da performance, em atletas com carência neste mineral. A creatina é bem tolerada e pode atuar como substância ergogénica. Conclusão: É escassa a evidência sobre as vantagens da suplementação em atletas adolescentes, devendo a decisão ser individualmente equacionada e vigiada por um profissional de saúde.
Article
Full-text available
هدفت الدراسة للتعرّف إلى تأثير تناول مكملات الأحماض الأمينيّة ذات السلسلة المتفرعة على مسافة الجري خلال اختبار كوبر وبعض علامات التعب العضليّ عند طلبة التفوّق الرياضيّ بجامعة اليرموك. استخدِم التصميم الأعمى العشوائيّ لمجموعة واحدة ضمَّت 11 طالب بعمر (20.73±1.39 سنة) خضعوا لتجربتيْن (بفاصل زمني أسبوعان). تضمن بروتوكول الدراسة قيام كل لاعب بتناول 25 غم BCAAs مذاباً في 500 مللتر قبل ساعتيْن من بدء التجربة (تجربة الأحماض الامينيّة) أو 500 مللتر ماء فقط (التجربة الضابطة). تضمنت كل تجربة إحماء لمدّة 5 دقائق، ومن ثمَّ إطالة لعضلات الذراعيْن والرجليْن لمدة 4 دقائق. بعد ذلك، خضع كل مشترك لاختبار كوبر (12 دقيقة جري). وبعد الانتهاء من كل تجربة تمَّ حساب المسافة المقطوعة وسحب عينة دم من كل مشترك لقياس متغيرات الدراسة. أظهرت النتائج أن مسافة الجري كانت أطول/أفضل في تجربة الأحماض الأمينيّة (3607 متر) مقارنة بالتجربة الضابطة (3501 متر) وبشكلٍ دالٍّ إحصائياً (α ≤ 0.05). أمَّا تركيز إنزيم ألدوليز ومستوى لاكتيت الدم كان أقل (أفضل) في تجربة الأحماض الأمينيّة مقارنة بالضابطة وبشكلٍ دالٍّ إحصائياً، بينما لم تظهر فروق إحصائيّة في سكر الدم ومعدّل ضربات القلب بين التجربتيْن. تمّ الاستنتاج أنَّ BCAAs عامل مُنتج للطاقة وتقلِّل من علامات التعب العضليّ.
Article
Full-text available
الملخص هدفت الدراسة للتعرّف إلى تأثير تناول مكملات الأحماض الأمينيّة ذات السلسلة المتفرعة على مسافة الجري خلال اختبار كوبر وبعض علامات التعب العضليّ عند طلبة التفوّق الرياضيّ بجامعة اليرموك. استخدِم التصميم الأعمى العشوائيّ لمجموعة واحدة ضمَّت 11 طالب بعمر (20.73±1.39 سنة) خضعوا لتجربتيْن (بفاصل زمني أسبوعان). تضمن بروتوكول الدراسة قيام كل لاعب بتناول 25 غم BCAAs مذاباً في 500 مللتر قبل ساعتيْن من بدء التجربة (تجربة الأحماض الامينيّة) أو 500 مللتر ماء فقط (التجربة الضابطة). تضمنت كل تجربة إحماء لمدّة 5 دقائق، ومن ثمَّ إطالة لعضلات الذراعيْن والرجليْن لمدة 4 دقائق. بعد ذلك، خضع كل مشترك لاختبار كوبر (12 دقيقة جري). وبعد الانتهاء من كل تجربة تمَّ حساب المسافة المقطوعة وسحب عينة دم من كل مشترك لقياس متغيرات الدراسة. أظهرت النتائج أن مسافة الجري كانت أطول/أفضل في تجربة الأحماض الأمينيّة (3607 متر) مقارنة بالتجربة الضابطة (3501 متر) وبشكلٍ دالٍّ إحصائياً (α ≤ 0.05). أمَّا تركيز إنزيم ألدوليز ومستوى لاكتيت الدم كان أقل (أفضل) في تجربة الأحماض الأمينيّة مقارنة بالضابطة وبشكلٍ دالٍّ إحصائياً، بينما لم تظهر فروق إحصائيّة في سكر الدم ومعدّل ضربات القلب بين التجربتيْن. تمّ الاستنتاج أنَّ BCAAs عامل مُنتج للطاقة وتقلِّل من علامات التعب العضليّ. الكلمات المفتاحية: أحماض أمينيّة ذات سلسلة متفرعة، اختبار كوبر، جري، تعب عضلي، مكملات.
Article
Full-text available
Caffeine, an adenosine receptor antagonist, has been studied for decades as a putative ergogenic aid. In the past 2 decades, the information has overwhelmingly demonstrated that it indeed is a powerful ergogenic aid, and frequently theories have been proposed that this is due to alterations in fat and carbohydrate metabolism. While caffeine certainly mobilizes fatty acids from adipose tissue, rarely have measures of the respiratory exchange ratio indicated an increase in fat oxidation. However, this is a difficult measure to perform accurately during exercise, and small changes could be physiologically important. The few studies examining human muscle metabolism directly have also supported the fact that there is no change in fat or carbohydrate metabolism, but these usually have had a small sample size. We combined the data from muscle biopsy analyses of several similar studies to generate a sample size of 16-44, depending on the measure. We examined muscle glycogen, citrate, acetyl-CoA, glucose-6-phosphate, and cyclic adenosine monophosphate (cAMP) in resting samples and in those obtained after 10-15 min of exercise at 70%-85% maximal oxygen consumption. Exercise decreased (p < 0.05) glycogen and increased (p < 0.05) citrate, acetyl-CoA, and glucose-6-phosphate. The only effects of caffeine were to increase (p < 0.05) citrate in resting muscle and cAMP in exercise. There is very little evidence to support the hypothesis that caffeine has ergogenic effects as a result of enhanced fat oxidation. Individuals may, however, respond differently to the effects of caffeine, and there is growing evidence that this could be explained by common genetic variations.
Article
Full-text available
We examined the effects of a high-caffeine dose on endurance performance and muscle acetyl group metabolism during prolonged exercise. Eight subjects cycled to exhaustion at approximately 80% maximal oxygen uptake (VO2max) 1 h after ingestion of 9 mg/kg body wt dextrose (Pl) or caffeine (Caf). In the Pl trial, muscle biopsies were taken at rest (1 h postingestion) and at 15 min and exhaustion during exercise. The Caf trial followed the same protocol 1 wk later, with an additional biopsy at the time corresponding to Pl exhaustion. The subjects cycled significantly longer during the Caf trial (96.2 +/- 8.8 min) than in the Pl trial (75.8 +/- 4.8 min). Net glycogenolysis during the initial 15 min of cycling was reduced in the Caf vs. Pl trial (4.7 +/- 1.5 vs. 10.6 +/- 1.3 mmol.kg dry muscle-1.min-1; P less than 0.05). Muscle citrate concentration was increased at rest with Caf (0.59 +/- 0.07 vs. 0.37 +/- 0.05 mmol/kg dry muscle; P less than 0.05) but increased to similar values in both trials during cycling. Caf elevated the acetyl-CoA/CoA-SH ratio at rest (0.316 +/- 0.046 vs. 0.201 +/- 0.023; P less than 0.05) but had no effect on the increases in muscle acetyl-CoA and acetylcarnitine during exercise. The results indicate that Caf before exercise decreased muscle glycogenolysis by approximately 55% over the first 15 min of exercise at approximately 80% VO2max. This "spared glycogen" was available late in exercise and coincided with a prolonged time to exhaustion. Increased utilization of intramuscular triacylglycerol and/or extramuscular free fatty acids after caffeine ingestion may inhibit carbohydrate use at rest and early during exercise via elevations in muscle citrate and the acetyl-CoA/CoA-SH ratio. Muscle acetyl-CoA and acetylcarnitine were maintained above resting contents even at exhaustion when muscle glycogen was depleted.
Article
The cellular role of creatine (Cr) and Cr phosphate (CrP) has been studied extensively in neural, cardiac and skeletal muscle. Several studies have demonstrated that alterations in the cellular total Cr (Cr + CrP) concentration in these tissues can produce marked functional and/or structural change. The primary aim of this review was to critically evaluate the literature that has examined the regulation of cellular total Cr content. In particular, the review focuses on the regulation of the activity and gene expression of the Cr transporter (CreaT), which is primarily responsible for cellular Cr uptake. Two CreaT genes (CreaT1 and CreaT2) have been identified and their chromosomal location and DNA sequencing have been completed. From these data, putative structures of the CreaT proteins have been formulated. Transcription products of the CreaT2 gene are expressed exclusively in the testes, whereas CreaT1 transcripts are found in a variety of tissues. Recent research has measured the expression of the CreaT1 protein in several tissues including neural, cardiac and skeletal muscle. There is very little information available about the factors regulating CreaT gene expression. There is some evidence that suggests the intracellular Cr concentration may be involved in the regulatory process but there is much more to learn before this process is understood. The activity of the CreaT protein is controlled by many factors. These include substrate concentration, transmembrane Na^+ gradients, cellular location, and various hormones. It is also likely that transporter activity is influenced by its phosphorylation state and by its interaction with other plasma membrane proteins. The extent of CreaT protein glycosylation may vary within cells, the functional significance of which remains unclear.
Article
1. The action of catecholamines on the transport and the distribution of Na and K and the resting membrane potential (E(M)) has been investigated in soleus muscles isolated from fed rats.2. In a substrate-free Krebs-Ringer bicarbonate buffer adrenaline (ADR) (6 x 10(-6)M) increased (22)Na efflux by 83%, (42)K influx by 34%, and E(M) by 10%. Similar effects were exerted by noradrenaline (NA), phenylephrine, salbutamol and isoprenaline. The effects of ADR on Na-K transport and E(M) were suppressed by ouabain (10(-3)M) and propranolol (10(-5)M), but not by thymoxamine (10(-5)M) or tetracaine (10(-4)M).3. Following 90 min of incubation in the presence of ADR (6 x 10(-6)M), the intracellular K/Na-ratio was increased threefold. NA produced almost the same change, and both catecholamines seem to induce a new steady-state distribution of Na and K which can be maintained for several hours in vitro.4. The effect of ADR on (22)Na efflux and E(M) could be detected at concentrations down to 6 x 10(-9) and 6 x 10(-10)M, respectively, and half-maximum increase was obtained at around 2 x 10(-8)M. NA was at least one order of magnitude less potent.5. The effect of low concentrations of ADR on (22)Na efflux was potentiated by theophylline (2 mM). When added together, dibutyryl-cyclic AMP and theophylline mimicked the action of ADR on (22)Na efflux, (42)K influx, Na/K content and E(M). Ouabain (10(-3)M) also suppressed the effect of dibutyryl-cyclic AMP and theophylline on Na-K transport.6. Following the addition of ouabain (10(-3)M), E(M) rapidly dropped from a mean of -71 to -63 mV, and then showed a slow linear fall for up to 4hr.7. The hyperpolarization induced by ADR was associated with a decrease in membrane conductance, (22)Na influx and (42)K efflux. The time course and the response to ouabain suggests that all of these effects are secondary to stimulation of the active coupled transport of Na and K.8. It is concluded that in rat soleus muscle, the active Na-K transport is electrogenic and susceptible to stimulation by catecholamines via beta-adrenoceptors. This effect is mediated by adenyl cyclase activation and may account for the increase in E(M) and the intracellular K/Na ratio.
Article
The human sweat gland secretory coil (SC) is comprised of myoepithelial (ME) and two types of secretory epithelial cells. The secretory cells include beta-adrenergic-sensitive (beta-S) cells [responsive to the beta-adrenergic agonist isoproterenol (IPR)] and beta-adrenergic insensitive (beta-I) cells. We have grown segments of SC in primary culture and found that under the conditions described here, only epithelial cells form outgrowths as indicated by morphological and physiological properties. As in the native SC epithelium, the secretory cells in primary culture were comprised of polygonal epithelial cells with a characteristic hyperpolarization of cell potentials (Vm) to cholinergic stimulation by mecholyl (magnitude of change of Vm = delta Vm = 21.5 +/- 1.3 mV, mean +/- SE, n = number of cells = 44). We have found both beta-S and beta-I cells as determined by unstimulated membrane potentials, sensitivity to IPR, and K+ conductance (GK+). The frequency distribution of unstimulated cells indicated two distinct populations of cells, one with high membrane potentials (Vm = -63 +/- 2.6 mV), which correlated with beta-S cells, and a second with low membrane potentials (Vm = -22 +/- 1.5 mV), which correlated with the beta-I cells. IPR depolarized the Vm of beta-S cells (delta Vm = 11.0 +/- 0.8 mV, n = 25) without affecting the Vm of beta-I cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
1. The present study was undertaken to test whether creatine given as a supplement to normal subjects was absorbed, and if continued resulted in an increase in the total creatine pool in muscle. An additional effect of exercise upon uptake into muscle was also investigated. 2. Low doses (1 g of creatine monohydrate or less in water) produced only a modest rise in the plasma creatine concentration, whereas 5 g resulted in a mean peak after 1 h of 795 (sd 104) μmol/l in three subjects weighing 76–87 kg. Repeated dosing with 5 g every 2 h sustained the plasma concentration at around 1000 μmol/l. A single 5 g dose corresponds to the creatine content of 1.1 kg of fresh, uncooked steak. 3. Supplementation with 5 g of creatine monohydrate, four or six times a day for 2 or more days resulted in a significant increase in the total creatine content of the quadriceps femoris muscle measured in 17 subjects. This was greatest in subjects with a low initial total creatine content and the effect was to raise the content in these subjects closer to the upper limit of the normal range. In some the increase was as much as 50%. 4. Uptake into muscle was greatest during the first 2 days of supplementation accounting for 32% of the dose administered in three subjects receiving 6 × 5 g of creatine monohydrate/day. In these subjects renal excretion was 40, 61 and 68% of the creatine dose over the first 3 days. Approximately 20% or more of the creatine taken up was measured as phosphocreatine. No changes were apparent in the muscle ATP content. 5. No side effects of creatine supplementation were noted. 6. One hour of hard exercise per day using one leg augmented the increase in the total creatine content of the exercised leg, but had no effect in the collateral. In these subjects the mean total creatine content increased from 118.1 (sd 3.0) mmol/kg dry muscle before supplementation to 148.5 (sd 5.2) in the control leg, and to 162.2 (sd 12.5) in the exercised leg. Supplementation and exercise resulted in a total creatine content in one subject of 182.8 mmol/kg dry muscle, of which 112.0 mmol/kg dry muscle was in the form of phosphocreatine.
The aim of this study was to specify the effects of caffeine on maximal anaerobic power (W max). A group of 14 subjects ingested caffeine (250 mg) or placebo in random double-blind order. TheW max was determined using a force-velocity exercise test. In addition, we measured blood lactate concentration for each load at the end of pedalling and after 5 min of recovery. We observed that caffeine increasedW max [964 (SEM 65.77) W with caffeine vs 903.7 (SEM 52.62) W with placebo;P<0.02] and blood lactate concentration both at the end of pedalling [8.36 (SEM 0.95) mmol · l−1 with caffeine vs 7.17 (SEM 0.53) mmol · l−1 with placebo;P<0.011 and after 5 min of recovery [10.23 (SEM 0.97) mmol · l−1 with caffeine vs 8.35 (SEM 0.66) mmol · l−1 with placebo;P<0.04]. The quotient lactate concentration/power (mmol · l−1 · W−1) also increased with caffeine at the end of pedalling [7.6 · 10−3 (SEM 3.82 · 10−5) vs 6.85 · 10−3 (SEM 3.01 · 10−5);P<0.01] and after 5 min of recovery [9.82·10−3 (SEM 4.28 · 10−5) vs 8.84 · 10−3 (SEM 3.58 · 10−5);P<0.02]. We concluded that caffeine increased bothW max and blood lactate concentration.
The physiological effects of caffeine on subjects habituated to caffeine is relatively unstudied compared to those of caffeine naive subjects during graded exercise. Thus, the purpose of this investigation was to determine the effects of caffeine on maximal oxygen consumption (VO2max) and the anaerobic threshold in these two populations. Seventeen moderately trained males were classified according to caffeine usage: (1) caffeine consumption 25 mg·day−1 or less (CN) (n=8) or (2) caffeine consumption above 300 mg·day−1 (CH) (n=9). The subjects were tested post-absorptive on the same cycle ergometer on three occasions with 7 days separating the tests. One hour before each test the subject ingested either a gelatin capsule (C); 3 mg·kg−1 body weight of caffeine (C3); or 5 mg·kg−1 body weight of caffeine (C5). The subject then performed an incrementalVO2max test beginning at 50 W and the work rate was increased 30 W every 2 min until the subject could not maintain the power output. Serial venous blood samples were drawn over 30 s at the end of each stage. The CN group significantly increased resting heart rate (f c) and expired ventilation volume (V E) after C3 and C5 andVO2 after C5. No significant differences were found for exerciseV E,VO2, respiratory excharge ratio,f c or time to exhaustion. There were no significant differences (P < 0.05) in the lactate threshold or the ventilatory threshold between treatment in either group. The CH subjects showed a significant increase (P<0.05) in resting plasma free fatty acid (FFA) concentration only during the C3 and C5 treatments. Plasma FFA levels were significantly increased (P < 0.05) at all times during C3 and C5 treatment in the CN subjects when compared to the control values. These data indicate that caffeine has no effect onVO2max or the anaerobic threshold seen during incremental, graded exercise. However, resting metabolism and ventilation, and both resting and exercise plasma FFA are increased in CN subjects.
Article
Nine male recreational cyclist served as subjects in this experiment which included a control, placebo and caffeine trial. The aim of the experiment was to determine whether a 10 mg.kg-1 dose of caffeine given three hours prior to an incremental cycle ergometer exercise test, for caffeine naive subjects, would increase the time to exhaustion and therefore increase the amount of work undertaken by the cyclists. The cyclists initially worked at 100 watts for three minutes and then increased the workload by 50 watts every three minutes until exhaustion. Blood was drawn at the beginning of the test and every three minutes from an ante-cubital vein and was analysed for blood lactate, glucose and free fatty acids (FFA). Respiratory analysis was also undertaken and heart rate was monitored throughout the test. Subjects in the caffeine trial worked significantly longer and performed more work (p less than 0.05) than they did in either the control or placebo trials. FFA's were also significantly higher in this trial (p less than 0.05) and the lactate threshold was moved to the right as a percentage of the VO2max, which suggests less acidity and a decreased bicarbonate flushing. The respiratory exchange ratio data was significantly lowered (p less than 0.05) during workloads between 250 and 450 watts. No changes were seen in blood glucose or heart rates during the experiment. In conclusion, we feel that a 10 mg.kg-1 dose of caffeine is an ergogenic aid during incremental exercise when it is taken 3-4 hours prior to the exercise in fasting subjects who have diets low in caffeine.